Pharmaceuticals and Drug Development Women May Not Recognize Non-Lump Symptoms of Breast Cancer Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 3, 2023. By Lori Solomon HealthDay Reporter FRIDAY, Nov. 3, 2023 — Fewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State […] Written by Carmen Pope November 4, 2023November 4, 2023 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development What does the future hold for healthcare? Pharma Integrates, 16 November 2023, The Mermaid, London Written by Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom November 3, 2023November 3, 2023 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults FLORHAM PARK, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the U.S. Food and Drug […] Written by Admin November 2, 2023November 2, 2023 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) Treatment for: Low-Grade Glioma Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) BRISBANE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people […] Written by Admin November 1, 2023November 1, 2023 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Sociodemographic Disparities Seen in Quality of Life in Children With Hearing Loss By Lori Solomon HealthDay Reporter TUESDAY, Oct. 31, 2023 — Race and ethnicity and neighborhood disadvantage are associated with hearing-related quality of life (QOL) in deaf or hard-of-hearing (DHH) children, according to a research letter published online Oct. 30 in JAMA Network Open. Brooke R. Warren, from the University of California in San Francisco, and […] Written by Admin October 31, 2023October 31, 2023 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Driving Precision Medicine Forward: Bio-It World Europe Convenes in London 29-30 November 2023 LONDON—To foster collaboration among the UK and Europe’s biopharma and technology leaders who are forging new frontiers in precision medicine, the Bio-IT World Conference & Expo Europe is coming to London 29-30 November 2023. Held in one of the world’s leading hubs for medical innovation, this annual event will focus on the latest IT […] Written by Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom October 30, 2023October 30, 2023 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development FDA Approves Omvoh (mirikizumab-mrkz), a First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis FDA Approves Omvoh (mirikizumab-mrkz), a First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh™ (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), the first and only interleukin-23p19 (IL-23p19) antagonist […] Written by Admin October 29, 2023October 29, 2023 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review Treatment for: Follicular Lymphoma, Diffuse Large B-Cell Lymphoma Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review TARRYTOWN, N.Y., Sept. 29, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority […] Written by Admin October 28, 2023October 28, 2023 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development TCT: TAVR, SAVR Comparable for Severe Aortic Stenosis, Small Aortic Annulus By Elana Gotkine HealthDay Reporter FRIDAY, Oct. 27, 2023 — For patients with severe aortic stenosis (AS) and small aortic annulus (SAA), valve hemodynamic results are comparable with use of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR), according to a study published online Oct. 26 in Circulation to coincide with the […] Written by Admin October 27, 2023October 27, 2023 Saving Bookmark this article Bookmarked
Pharmaceuticals and Drug Development Going green in pharmaceuticals London, 25/10/2023: The pharmaceutical industry is currently responsible for over four per cent of global carbon emissions and this figure is on track to grow in the coming years. The UK Government has committed in legislation to reach net-zero carbon emissions by 2050, but achieving this goal could hinge on whether or not the industry […] Written by Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom October 26, 2023October 26, 2023 Saving Bookmark this article Bookmarked
Researchers outline new approach for better understanding animal consciousness A team of researchers has outlined a new approach for better understanding the depths of animal consciousness, a method that may yield new insights into the similarities and differences among living organisms. The essay, which appears in the journal Science, describes a “marker method” that scientists can use to assess animal consciousness. It involves identifying […] Written by Admin February 21, 2025February 21, 2025 Saving Bookmark this article Bookmarked
Unveiling the Elasticity Secrets of Flexible Crystals Australian researchers have achieved significant breakthroughs in understanding the intrinsic properties of flexible crystalline materials, paving the way for potential advancements in the fields of building materials, electronics, and various technologies. The research team, which includes experts from The University of Queensland (UQ) and Queensland University of Technology (QUT), focused their investigation on the elastic […] Written by Bioengineer February 21, 2025February 21, 2025 Saving Bookmark this article Bookmarked
Researchers outline new approach for better understanding animal consciousness A team of researchers has outlined a new approach for better understanding the depths of animal consciousness, a method that may yield new insights into the similarities and differences among living organisms. The essay, which appears in the journal Science, describes a “marker method” that scientists can use to assess animal consciousness. It involves identifying […] Written by Admin February 21, 2025February 21, 2025 Saving Bookmark this article Bookmarked
Unveiling the Elasticity Secrets of Flexible Crystals Australian researchers have achieved significant breakthroughs in understanding the intrinsic properties of flexible crystalline materials, paving the way for potential advancements in the fields of building materials, electronics, and various technologies. The research team, which includes experts from The University of Queensland (UQ) and Queensland University of Technology (QUT), focused their investigation on the elastic […] Written by Bioengineer February 21, 2025February 21, 2025 Saving Bookmark this article Bookmarked
Urban environments promote adaptation to multiple stressors Animal populations from urban areas show significantly higher resilience to stressful environmental conditions. This was found by an international team of researchers led by Dr Elizabeta Briski from the GEOMAR Helmholtz Centre for Ocean Research Kiel, Germany. The mussel and crustacean species studied were able to adapt to disturbed environments, making them more resistant to […] Written by Admin February 20, 2025February 20, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked